Clinical Trials on Alternative Medicines for COVID-19.

Abstract

In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.

• Authors: Bassam Ali Jaber, Rizwan Qureshi, Alaa Abd-Alrazaq, Mohammad Azizur Rahman, Mowafa Househ, Zubair Shah, Tanvir Alam
• Journal: Studies in health technology and informatics (Stud Health Technol Inform) Vol. 295 Pg. 366-369 (Jun 29 2022) ISSN: 1879-8365 [Electronic] Netherlands
• PMID: 35773886 (Publication Type: Journal Article)

Chemical References

• Vitamin D
• Ascorbic Acid
• Resveratrol

Topics

• Ascorbic Acid
• Clinical Trials as Topic
• Complementary Therapies
• Dietary Supplements
• Humans
• Phytotherapy
• Resveratrol (therapeutic use)
• SARS-CoV-2
• Vitamin D (therapeutic use)
• COVID-19 Drug Treatment